RE:RE:Facebook PostsWhat I really liked about one of the latest interviews with Booth was that he said they remain focused on the canadian market. This is good for canadians. Running out of supply as one 'poster' commented should not be taken lightly for medicinal users... when they find a strain / medication that works for them they arent inclined to just try something 'similiar'. They want what works for them. Aurora is my main investment and I want them to succeed.